FDA Delays Pfizer COVID-19 Shot Decision For Children Ages 5 And Under; Awaiting Results Of New Study

CHICAGO (CBS) -- The U.S Food and Drug Administration is delaying a decision on COVID-19 shots for children under 5 years of age.

The vaccine was scheduled for next week but the agency decided to wait for the results of a new study on a third dose.

Early data from Pfizer shows a two-shot lower dose regimen is safe for babies as young as 6 months.

But it didn't provide as much of an immune response in 2 to 4-year-olds.

18 million children in the U.S. under five are the only age group not currently eligible for the COVID vaccine.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.